Corcept Therapeutics Incorporated (CORT)

Debt-to-capital ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	506,705	501,842	375,806	523,338	371,182
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $506,705K)
= 0.00

The debt-to-capital ratio for Corcept Therapeutics Inc has consistently been 0.00 for the past five years, from 2019 to 2023. This indicates that the company has not relied on debt financing to fund its operations or growth, and instead has mainly relied on equity financing. A debt-to-capital ratio of 0.00 signifies that the company has no debt in its capital structure, resulting in a lower financial risk profile as there are no interest payments to be made. However, it is important to note that while a low debt-to-capital ratio can be favorable in terms of financial risk, it may also suggest limited leverage and potential constraints on the company's ability to take advantage of growth opportunities that could be funded through debt. Overall, the stable and consistently low debt-to-capital ratio for Corcept Therapeutics Inc reflects a conservative financial strategy that prioritizes equity financing over debt.